$FONR
FONAR CORP Stock $fonr

$fonr Overview Financials Valuation SEC Filings Company Website

2014 Form 10-K Financial Statement

#000035501914000031 Filed on September 29, 2014

Income Statement

Concept	2014	2013 Q2	2013
Revenue	$1.964M	$18.38M	$1.200M
YoY Change	63.65%	67.24%	48.15%
Cost Of Revenue	$1.067M	$10.69M	$3.657M
YoY Change	-70.82%	82.42%	-32.13%
Gross Profit	$896.6K	$7.690M	-$2.457M
YoY Change	-136.5%	49.61%	-46.34%
Gross Profit Margin	45.66%	41.84%	-204.72%
Selling, General & Admin	$18.58M	$4.970M	$12.50M
YoY Change	48.66%	72.57%	42.89%
% of Gross Profit	2072.72%	64.63%
Research & Development	$1.761M	$410.0K	$1.439M
YoY Change	22.4%	36.67%	15.76%
% of Gross Profit	196.38%	5.33%
Depreciation & Amortization	$3.817M	$930.0K	$2.421M
YoY Change	57.66%	55.0%	8.56%
% of Gross Profit	425.73%	12.09%
Operating Expenses	$20.35M	$5.380M	$13.94M
YoY Change	45.95%	69.18%	39.52%
Operating Profit	-$19.45M	$2.310M	-$16.40M
YoY Change	18.61%	17.86%	12.54%
Interest Expense	-$884.5K	-$200.0K	-$500.4K
YoY Change	76.78%	150.0%	-204.53%
% of Operating Profit		-8.66%
Other Income/Expense, Net	-$4.835K	$740.0K	-$142.0K
YoY Change	-96.59%	-7500.0%	1174.54%
Pretax Income	$11.05M	$2.850M	$7.978M
YoY Change	38.48%	53.23%	13.72%
Income Tax	-$2.348M	-$2.430M	$2.278M
% Of Pretax Income	-21.25%	-85.26%	28.55%
Net Earnings	$10.40M	$4.800M	$8.679M
YoY Change	19.79%	235.66%	50.24%
Net Earnings / Revenue	529.4%	26.12%	723.21%
Basic Earnings Per Share	$1.73		$1.46
Diluted Earnings Per Share	$1.705M	$786.9K	$1.426M
COMMON SHARES
Basic Shares Outstanding	6.010M shares		5.933M shares
Diluted Shares Outstanding	6.137M shares		6.061M shares

Balance Sheet

Concept	2014	2013 Q2	2013
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.00M	$7.900M	$7.900M
YoY Change	26.58%	-34.17%	-34.17%
Cash & Equivalents	$10.00M	$7.871M	$7.900M
Short-Term Investments
Other Short-Term Assets	$1.000M	$1.100M	$1.100M
YoY Change	-9.09%	266.67%	266.67%
Inventory	$3.200M	$2.500M	$2.500M
Prepaid Expenses
Receivables	$28.70M	$26.40M	$26.40M
Other Receivables	$0.00	$8.126M	$0.00
Total Short-Term Assets	$42.80M	$37.87M	$37.90M
YoY Change	12.93%	46.4%	46.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.00M	$17.52M	$17.50M
YoY Change	-14.29%	452.22%	446.88%
Goodwill		$1.767M
YoY Change
Intangibles		$11.90M
YoY Change		310304.17%
Long-Term Investments
YoY Change
Other Assets	$6.700M	$4.100M	$4.100M
YoY Change	63.41%	485.71%	485.71%
Total Long-Term Assets	$34.00M	$35.33M	$35.30M
YoY Change	-3.68%	356.83%	358.44%
TOTAL ASSETS
Total Short-Term Assets	$42.80M	$37.87M	$37.90M
Total Long-Term Assets	$34.00M	$35.33M	$35.30M
Total Assets	$76.80M	$73.20M	$73.20M
YoY Change	4.92%	117.86%	117.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.500M	$2.752M	$2.800M
YoY Change	-10.71%	32.53%	33.33%
Accrued Expenses	$7.900M	$8.100M	$8.100M
YoY Change	-2.47%	8.0%	8.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.900M	$2.900M	$2.900M
YoY Change	0.0%	52.63%	52.63%
Total Short-Term Liabilities	$20.90M	$21.12M	$21.10M
YoY Change	-0.95%	0.18%	0.0%
LONG-TERM LIABILITIES
Long-Term Debt	$8.500M	$12.90M	$12.90M
YoY Change	-34.11%	1512.5%	1512.5%
Other Long-Term Liabilities	$900.0K	$900.0K	$900.0K
YoY Change	0.0%	28.57%	28.57%
Total Long-Term Liabilities	$9.400M	$14.23M	$13.80M
YoY Change	-31.88%	878.72%	820.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.90M	$21.12M	$21.10M
Total Long-Term Liabilities	$9.400M	$14.23M	$13.80M
Total Liabilities	$51.50M	$35.35M	$59.00M
YoY Change	-12.71%	56.88%	106.29%
SHAREHOLDERS EQUITY
Retained Earnings		-$159.7M
YoY Change		-5.16%
Common Stock		$174.5M
YoY Change		0.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$675.0K
YoY Change		0.0%
Treasury Stock Shares
Shareholders Equity	$25.30M	$37.80M	$14.10M
YoY Change
Total Liabilities & Shareholders Equity	$76.80M	$73.15M	$73.20M
YoY Change	4.92%	117.48%	117.86%

Cashflow Statement

Concept	2014	2013 Q2	2013
OPERATING ACTIVITIES
Net Income	$10.40M	$4.800M	$8.679M
YoY Change	19.79%	235.66%	50.24%
Depreciation, Depletion And Amortization	$3.817M	$930.0K	$2.421M
YoY Change	57.66%	55.0%	8.56%
Cash From Operating Activities	$13.39M	$1.180M	$7.539M
YoY Change	77.62%	-61.69%	1.7%
INVESTING ACTIVITIES
Capital Expenditures	-$620.7K	-$620.0K	-$1.135M
YoY Change	-45.33%	16.98%	-205.01%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$19.80M	-$40.00M
YoY Change	-100.0%	98900.0%
Cash From Investing Activities	-$834.9K	-$20.42M	-$41.30M
YoY Change	-97.98%	3612.73%	3264.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$10.48M	17.86M	$29.59M
YoY Change	-135.39%	-1282.78%	-969.11%
NET CHANGE
Cash From Operating Activities	$13.39M	1.180M	$7.539M
Cash From Investing Activities	-$834.9K	-20.42M	-$41.30M
Cash From Financing Activities	-$10.48M	17.86M	$29.59M
Net Change In Cash	$2.081M	-1.380M	-$4.161M
YoY Change	-150.01%	-235.29%	-249.65%
FREE CASH FLOW
Cash From Operating Activities	$13.39M	$1.180M	$7.539M
Capital Expenditures	-$620.7K	-$620.0K	-$1.135M
Free Cash Flow	$14.01M	$1.800M	$8.675M
YoY Change	61.53%	-50.14%	36.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q3	dei	Entity Public Float EntityPublicFloat	125000000	usd
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6050840	shares
CY2014Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	9951736	usd
CY2013Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	7870727	usd
CY2014Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs CostsInExcessOfBillingsOnUncompletedContractsOrPrograms	759809	usd
CY2013Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs CostsInExcessOfBillingsOnUncompletedContractsOrPrograms	445742	usd
CY2014Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	2443536	usd
CY2013Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	2077088	usd
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1011358	usd
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1054551	usd
CY2014Q2	us-gaap	Assets Current AssetsCurrent	42821790	usd
CY2013Q2	us-gaap	Assets Current AssetsCurrent	37865756	usd
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15029729	usd
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17524494	usd
CY2014Q2	us-gaap	Other Assets OtherAssets	922096	usd
CY2013Q2	us-gaap	Other Assets OtherAssets	1153304	usd
CY2014Q2	us-gaap	Assets Net AssetsNet	76789843	usd
CY2013Q2	us-gaap	Assets Net AssetsNet	73150650	usd
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2481997	usd
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2752479	usd
CY2014Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	9024033	usd
CY2013Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8494361	usd
CY2014Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4730962	usd
CY2013Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4965415	usd
CY2014Q2	us-gaap	Billings In Excess Of Cost Current BillingsInExcessOfCostCurrent	142217	usd
CY2013Q2	us-gaap	Billings In Excess Of Cost Current BillingsInExcessOfCostCurrent	142217	usd
CY2014Q2	us-gaap	Accrued Income Taxes AccruedIncomeTaxes		usd
CY2013Q2	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	19501	usd
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	21196838	usd
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	21117612	usd
CY2014Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	234581	usd
CY2013Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	230626	usd
CY2014Q2	us-gaap	Other Liabilities OtherLiabilities	386012	usd
CY2013Q2	us-gaap	Other Liabilities OtherLiabilities	654273	usd
CY2014Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	9686413	usd
CY2013Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14233762	usd
CY2014Q2	us-gaap	Liabilities Liabilities	30883251	usd
CY2013Q2	us-gaap	Liabilities Liabilities	35351374	usd
CY2014Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	175284437	usd
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	174499020	usd
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-149259286	usd
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-159655416	usd
CY2014Q2	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	-38828	usd
CY2013Q2	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	-54820	usd
CY2014Q2	us-gaap	Treasury Stock Deferred Employee Stock Ownership Plan TreasuryStockDeferredEmployeeStockOwnershipPlan	-675390	usd
CY2013Q2	us-gaap	Treasury Stock Deferred Employee Stock Ownership Plan TreasuryStockDeferredEmployeeStockOwnershipPlan	-675390	usd
CY2014Q2	us-gaap	Minority Interest MinorityInterest	20594984	usd
CY2013Q2	us-gaap	Minority Interest MinorityInterest	23685215	usd
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	45906592	usd
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	37799276	usd
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	11101065	usd
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	76789843	usd
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	73150650	usd
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	68505477	usd
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	49141814	usd
CY2014	us-gaap	Net Income Loss NetIncomeLoss	10396130	usd
CY2013	us-gaap	Net Income Loss NetIncomeLoss	8678542	usd
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6009822	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5933318	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6137326	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6060822	shares
CY2014	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3817205	usd
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2421177	usd
CY2014	FONR	Abandoned Patents Written Off AbandonedPatentsWrittenOff	250523	usd
CY2013	FONR	Abandoned Patents Written Off AbandonedPatentsWrittenOff	66619	usd
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation		usd
CY2014	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	531825	usd
CY2013	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4044002	usd
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3717440	usd
CY2014	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-314067	usd
CY2013	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	682854	usd
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-366448	usd
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	117861	usd
CY2014	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	46967	usd
CY2013	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-698284	usd
CY2014	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	131811	usd
CY2013	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-204037	usd
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	620697	usd
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1135382	usd
CY2014	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	214211	usd
CY2013	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	159907	usd
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-834908	usd
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41295289	usd
CY2014	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		usd
CY2013	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	19800000	usd
CY2014	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt		usd
CY2013	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	14689646	usd
CY2014	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	4400128	usd
CY2013	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1821617	usd
CY2014	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	-15992	usd
CY2013	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	-15993	usd
CY2014	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	4965770	usd
CY2013	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	1799950	usd
CY2014	FONR	Distributions To Noncontrolling Interests DistributionsToNoncontrollingInterests	-4965770	usd
CY2013	FONR	Distributions To Noncontrolling Interests DistributionsToNoncontrollingInterests	-1799950	usd
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10444406	usd
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29594857	usd
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2081009	usd
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4161288	usd
CY2013Q2	FONR	Cash And Cash Equivalents Beginning Of Year CashAndCashEquivalentsBeginningOfYear	7870727	usd
CY2012Q2	FONR	Cash And Cash Equivalents Beginning Of Year CashAndCashEquivalentsBeginningOfYear	12032015	usd
CY2014Q2	FONR	Cash And Cash Equivalents End Of Year CashAndCashEquivalentsEndOfYear	9951736	usd
CY2013Q2	FONR	Cash And Cash Equivalents End Of Year CashAndCashEquivalentsEndOfYear	7870727	usd
CY2014	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	223000	usd
CY2013	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	415021	usd
CY2013	FONR	Payments On Notes Receivable From Employee Stockholders PaymentsOnNotesReceivableFromEmployeeStockholders	15993	usd
CY2013	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	-1424900	usd
CY2014	FONR	Capital Stock And Options Disclosure Textblock CapitalStockAndOptionsDisclosureTextblock	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 8 - CAPITAL STOCK</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Common Stock</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Class B Common Stock</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Class B common stock is convertible into shares of common stock on a one-for-one basis. Class B common stock has 10 votes per share. There were 146 and 146 of such shares outstanding at June 30, 2014 and 2013, respectively.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Class C Common Stock</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On April 3, 1995, the stockholders ratified a proposal creating a new Class C common stock and authorized the exchange offering of three shares of Class C common stock for each share of the Company's outstanding Class B common stock. The Class C common stock has 25 votes per share, as compared to 10 votes per share for the Class B common stock and one vote per share for the common stock. The Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock. Although having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions. Class C common stock is convertible into shares of common stock on a three-for-one basis.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Class A Non-Voting Preferred Stock</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On April 3, 1995, the stockholders ratified a proposal consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the declaration of a stock dividend on the Company's common stock consisting of one share of Class A non-voting preferred stock for every five shares of common stock. The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such stock dividend approximates 313,000 shares.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock is entitled to a special dividend equal to 3-1/4% of first $10 million, 4-1/2% of next $20 million and 5-1/2% on amounts in excess of $30 million of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company's patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company's patents.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock participates on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution rights, liquidation rights and other rights and preferences (other than the voting rights).</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Stock Bonus Plans</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On April 23, 2010, the Board approved the 2010 Stock Bonus Plan. The plan entitles the Company to reserve 2,000,000 shares of common stock. On August 10, 2010, the Company filed Form S-8 to register the 2,000,000 shares. As of June 30, 2014, 958,367 shares of common stock of FONAR were available for future grant under this plan. For the years ended June 30, 2014 and 2013, 46,708 and 67,870 shares were issued, respectively.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Options</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company has stock option plans, which provide for the awarding of incentive and non-qualified stock options to employees, directors and consultants who may contribute to the success of the Company. The options granted vest either immediately or ratably over a period of time from the date of grant, typically three or four years, at a price determined by the Board of Directors or a committee of the Board of Directors, generally the fair value of the Company's common stock at the date of grant. The options must be exercised within ten years from the date of grant.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FONARs 2002 Incentive Stock Option Plan (the FONAR 2002 Plan), adopted on July 1, 2002, is intended to qualify as an incentive stock option plan under Section 422A of the Internal Revenue Code of 1954, as amended. The FONAR 2002 Plan permits the issuance of stock options covering an aggregate of 100,000 shares of common stock of FONAR. The options have an exercise price equal to the fair market value of the underlying stock on the date the option is granted, are nontransferable, are exercisable for a period not exceeding ten years and expire upon the voluntary termination of employment. The FONAR 2002 Plan terminated on June 30, 2012. During the year ended June 30, 2014, 6,610 options expired, therefore no options remain outstanding.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FONARs 2005 Incentive Stock Option Plan (the FONAR 2005 Plan), adopted on February 16, 2005,is intended to qualify as an incentive stock option plan under Section 422A of the Internal Revenue Code of 1954, as amended. The FONAR 2005 Plan permits the issuance of stock options covering an aggregate of 80,000 shares of common stock of FONAR. The options have an exercise price equal to the fair value of the underlying stock on the date the option is granted, are non-transferable, are exercisable for a period not exceeding ten years, and expire upon the voluntary termination of employment. The FONAR 2005 Plan will terminate on February 14, 2015. As of June 30, 2014, 70,000 shares of common stock of FONAR were available for future grant under this Plan.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Stock option activity and weighted average exercise prices under these plans and grants for the years ended June 30, 2014 and 2013 were as follows:</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%; font: 9pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Number of Options</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Aggregate Intrinsic Value</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; padding-left: 5.4pt">Outstanding, June 30, 2012</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">14,022</td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">27.76</td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">  </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Forfeited / Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,412</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">26.65</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Outstanding, June 30, 2013</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,610</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Forfeited / Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(6,610</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">29.00</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">Outstanding, June 30, 2014</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Exercisable at:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 8.85pt; padding-left: 5.4pt">June 30, 2013</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,610</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">29.00</td><td style="text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: 8.85pt; padding-left: 5.4pt">June 30, 2014</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">  </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">  </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p>
CY2014	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Courier New, Courier, Monospace; margin: 0; text-align: justify"></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Use of Estimates</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies, revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue to impact the Company's operations and the determination of contractual and other allowance estimates. Actual results could differ from those estimates.</p> <p style="font: 10pt Courier New, Courier, Monospace; margin: 0; text-align: justify"></p>
CY2014	us-gaap	Revenue Recognition Percentage Of Completion Method RevenueRecognitionPercentageOfCompletionMethod	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue on sales contracts for scanners, included in product sales in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion method in accordance with FASB ASC 605-35, Revenue Recognition Construction-Type and Production-Type Contracts. The Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation take approximately three to six months.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue from sales of other items is recognized upon shipment.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with various medical providers (the "PCs"). As of June 30, 2014, the Company has twenty management agreements of which three are with PCs owned by Raymond V. Damadian, M.D., President and Chairman of the Board of FONAR (the Related medical practices) and seventeen are with PCs, which are all located in the state of New York (the New York PCs), owned by two unrelated radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately $35,000 to $242,000. All fees are re-negotiable at the anniversary of the agreements and each year thereafter. Revenue under lease contracts is recognized based upon contractual agreements for the leasing of medical equipment primarily under long term contracts to various unrelated PCs. The lease fees for the medical equipment consist of fixed monthly fees ranging from $2,000 to $19,000. All fees are re-negotiable at the anniversary of the agreements and each year thereafter.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Patient fee revenue, net of contractual allowance and discounts, consist of net patient fees received from insurance companies, third party payors (including federal and state agencies under Medicare and Medicaid programs), hospitals and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments and discounts. Patient fee revenue is recorded in the period in which services are provided.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Companys patient fee revenue, net of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2014 and 2013 are summarized in the following table.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 90%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="text-align: center; vertical-align: bottom"> <td> </td><td> </td> <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid">For the Year Ended June 30,</td></tr> <tr style="text-align: center; vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="border-bottom: Black 1pt solid">2014</td><td> </td> <td colspan="3" style="border-bottom: Black 1pt solid">2013</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left; text-indent: -8.85pt; padding-left: 8.85pt">Commercial Insurance/ Managed Care</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">4,217,088</td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,360,536</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.85pt; padding-left: 8.85pt">Medicare/Medicaid</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,443,020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">541,602</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.85pt; padding-left: 8.85pt">Workers' Compensation/Personal Injury</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,369,956</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,597,416</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.85pt; padding-left: 8.85pt">Other</td><td> </td> <td style="text-align: left; border-bottom: Black 1pt solid"> </td><td style="text-align: right; border-bottom: Black 1pt solid">5,277,128</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left; border-bottom: Black 1pt solid"> </td><td style="text-align: right; border-bottom: Black 1pt solid">1,982,311</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.85pt; padding-left: 8.85pt">Patient Fee Revenue, net of contractual allowances and discounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,307,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,481,865</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.85pt; padding-left: 8.85pt">Provision for Bad Debts</td><td> </td> <td style="text-align: left; border-bottom: Black 1pt solid"> </td><td style="text-align: right; border-bottom: Black 1pt solid">(10,333,082</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left; border-bottom: Black 1pt solid"> </td><td style="text-align: right; border-bottom: Black 1pt solid">(2,584,669</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.85pt; padding-left: 8.85pt">Net Patient Fee Revenue</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,974,110</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,897,196</td></tr></table>
CY2014	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<p style="font: 10pt/92% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Customer Advances</u></p> <p style="font: 10pt/92% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt/92% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition begins.</p>
CY2014	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Courier New, Courier, Monospace; margin: 0; text-align: justify"><font style="font: 10pt Arial, Helvetica, Sans-Serif"><u></u></font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Concentration of Credit Risk</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash: The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2014, the Company had cash on deposit of approximately $8,035,000 in excess of federally insured limits of $250,000.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Related Parties: Net revenues from related parties accounted for approximately 11% and 16% of the consolidated net revenues for the years ended June 30, 2014 and 2013, respectively. Net management fee receivables from the related medical practices accounted for approximately 12% and 9% of the consolidated accounts receivable for the years ended June 30, 2014 and 2013, respectively.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">See Note 3 regarding the Companys concentrations in the healthcare industry.</p> <p style="font: 10pt Courier New, Courier, Monospace; margin: 0; text-align: justify"></p>
CY2014	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Reclassifications</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Certain prior year amounts have been reclassified to conform to the current year presentation. The reclassifications did not have any effect on reported net income for any periods presented.</p>
CY2014Q2	us-gaap	Other Inventory Supplies OtherInventorySupplies	2093671	usd
CY2013Q2	us-gaap	Other Inventory Supplies OtherInventorySupplies	1783847	usd
CY2014Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	349865	usd
CY2013Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	293241	usd
CY2014Q2	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	620307	usd
CY2013Q2	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	620307	usd
CY2014Q2	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	17396797	usd
CY2013Q2	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	18567787	usd
CY2014Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	3510224	usd
CY2013Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	3500902	usd
CY2014Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2069055	usd
CY2013Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4987159	usd
CY2014Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2550627	usd
CY2013Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2952449	usd
CY2014Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5593148	usd
CY2013Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5669338	usd
CY2014Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	939614	usd
CY2013Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	939614	usd
CY2014Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	32679772	usd
CY2013Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	37237556	usd
CY2014Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17650043	usd
CY2013Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19713062	usd
CY2014Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7418436	usd
CY2013Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7668959	usd
CY2014Q2	FONR	Patents And Copyrights Less Amortization PatentsAndCopyrightsLessAmortization	4408011	usd
CY2013Q2	FONR	Patents And Copyrights Less Amortization PatentsAndCopyrightsLessAmortization	4193800	usd
CY2014Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9217604	usd
CY2013Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7858511	usd
CY2014Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10508843	usd
CY2013Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11904248	usd
CY2014Q2	FONR	Balance Beginning Of Year Balance_BeginningOfYear	11904248	usd
CY2013Q2	FONR	Balance Beginning Of Year Balance_BeginningOfYear	3835179	usd
CY2014Q2	FONR	Amounts Capitalized Other Intangible Assets AmountsCapitalizedOtherIntangibleAssets	214211	usd
CY2013Q2	FONR	Amounts Capitalized Other Intangible Assets AmountsCapitalizedOtherIntangibleAssets	9359907	usd
CY2014Q2	FONR	Abandon Patents Written Off AbandonPatentsWrittenOff	-250523	usd
CY2013Q2	FONR	Abandon Patents Written Off AbandonPatentsWrittenOff	-66619	usd
CY2014Q2	FONR	Balance End Of Year Balance_EndOfYear	10508843	usd
CY2013Q2	FONR	Balance End Of Year Balance_EndOfYear	11904248	usd
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6610	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14022	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	27.76
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	26.65
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue
CY2014	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-310000	usd
CY2013	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-125000	usd
CY2014	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-24093	usd
CY2013	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-71001	usd
CY2014Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	6961016	usd
CY2013Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	6139291	usd
CY2014Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	65108	usd
CY2013Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	264062	usd
CY2014Q2	FONR	Tax Credit Carryforward TaxCreditCarryforward	5644097	usd
CY2013Q2	FONR	Tax Credit Carryforward TaxCreditCarryforward	5873204	usd
CY2014Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	195408	usd
CY2013Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	1070291	usd
CY2014Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	67896587	usd
CY2013Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	71483815	usd
CY2014Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-62156300	usd
CY2013Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-68548065	usd
CY2014Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5740287	usd
CY2013Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2935750	usd
CY2014Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts		usd
CY2013Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts		usd
CY2014Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	-583990	usd
CY2013Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	-461858	usd
CY2014Q2	us-gaap	Deferred Tax Liabilities Gross Current DeferredTaxLiabilitiesGrossCurrent	-583990	usd
CY2013Q2	us-gaap	Deferred Tax Liabilities Gross Current DeferredTaxLiabilitiesGrossCurrent	-461858	usd
CY2014Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	5156297	usd
CY2013Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2473892	usd
CY2014Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	834324	usd
CY2013Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	710897	usd
CY2014Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	117480	usd
CY2013Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	117480	usd
CY2014Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	664349	usd
CY2013Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	809349	usd
CY2014Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2665181	usd
CY2013Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2858652	usd
CY2014Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	438730	usd
CY2013Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	569049	usd
CY2014Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	325139	usd
CY2013Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	305000	usd
CY2014Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	306092	usd
CY2013Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	13443	usd
CY2014Q2	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent		usd
CY2013Q2	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	250000	usd
CY2014Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	848399	usd
CY2013Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	390968	usd
CY2014Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	3753050	usd
CY2014Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	3042814	usd
CY2014Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1295636	usd
CY2014Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	835680	usd
CY2014Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	351732	usd
CY2014Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	894072	usd
CY2014Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	10172984	usd
CY2014Q2	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	152166	usd
CY2014Q2	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	96000	usd
CY2014Q2	us-gaap	Other Commitment OtherCommitment	305916	usd
CY2014	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2013	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-48777	usd
CY2014	us-gaap	Revenues Revenues	1963750	usd
CY2013	us-gaap	Revenues Revenues	1200000	usd
CY2014	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	12302669	usd
CY2013	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7535747	usd
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3817205	usd
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2421177	usd
CY2014	FONR	Compensatory Element Of Stock Issuances CompensatoryElementOfStockIssuances	223000	usd
CY2013	FONR	Compensatory Element Of Stock Issuances CompensatoryElementOfStockIssuances	415021	usd
CY2014	FONR	Identifiable Assets IdentifiableAssets	76789843	usd
CY2013	FONR	Identifiable Assets IdentifiableAssets	73150650	usd
CY2014	FONR	Capital Expenditures CapitalExpenditures	834908	usd
CY2013	FONR	Capital Expenditures CapitalExpenditures	25407939	usd
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1877932	usd
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	3939140	usd
CY2014	us-gaap	Maintenance Revenue MaintenanceRevenue	10082631	usd
CY2013	us-gaap	Maintenance Revenue MaintenanceRevenue	10841935	usd
CY2014	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	110000	usd
CY2013	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	110000	usd
CY2014	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	24307192	usd
CY2013	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	7481865	usd
CY2014	us-gaap	Management Fees Revenue ManagementFeesRevenue	34839969	usd
CY2013	us-gaap	Management Fees Revenue ManagementFeesRevenue	21493599	usd
CY2014	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	7620835	usd
CY2013	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	7859944	usd
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1067120	usd
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	3656635	usd
CY2014	us-gaap	Maintenance Costs MaintenanceCosts	2496985	usd
CY2013	us-gaap	Maintenance Costs MaintenanceCosts	3213420	usd
CY2014	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	27242	usd
CY2013	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	32603	usd
CY2014	us-gaap	Service Management Costs ServiceManagementCosts	20851065	usd
CY2013	us-gaap	Service Management Costs ServiceManagementCosts	12998243	usd
CY2014	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	5134553	usd
CY2013	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	3515706	usd
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1760821	usd
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1438560	usd
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15388239	usd
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12501621	usd
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1806299	usd
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1544521	usd
CY2014	us-gaap	Costs And Expenses CostsAndExpenses	56202808	usd
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	41606067	usd
CY2014	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	12302669	usd
CY2013	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	7535747	usd
CY2014	us-gaap	Interest Expense InterestExpense	884541	usd
CY2013	us-gaap	Interest Expense InterestExpense	500362	usd
CY2014	us-gaap	Investment Income Net InvestmentIncomeNet	238928	usd
CY2013	us-gaap	Investment Income Net InvestmentIncomeNet	217598	usd
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11048457	usd
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7978471	usd
CY2014	us-gaap	Profit Loss ProfitLoss	13396769	usd
CY2013	us-gaap	Profit Loss ProfitLoss	10256362	usd
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3000639	usd
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1577820	usd
CY2014	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	1037000	usd
CY2013	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	598000	usd
CY2014	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2013	us-gaap	Asset Impairment Charges AssetImpairmentCharges	357500	usd
CY2014	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	10333082	usd
CY2013	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	2584669	usd
CY2014	us-gaap	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	13974110	usd
CY2013	us-gaap	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	4897196	usd
CY2014	us-gaap	Revenue Recognition Allowances RevenueRecognitionAllowances	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Patient Fee Revenue - Net</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 90%"> <tr style="text-align: center; vertical-align: bottom"> <td> </td><td> </td> <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid">For the Year Ended June 30,</td></tr> <tr style="text-align: center; vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="border-bottom: Black 1pt solid">2014</td><td> </td> <td colspan="3" style="border-bottom: Black 1pt solid">2013</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left; text-indent: -8.85pt; padding-left: 8.85pt">Commercial Insurance/ Managed Care</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">4,217,088</td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,360,536</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.85pt; padding-left: 8.85pt">Medicare/Medicaid</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,443,020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">541,602</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.85pt; padding-left: 8.85pt">Workers' Compensation/Personal Injury</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,369,956</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,597,416</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.85pt; padding-left: 8.85pt">Other</td><td> </td> <td style="text-align: left; border-bottom: Black 1pt solid"> </td><td style="text-align: right; border-bottom: Black 1pt solid">5,277,128</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left; border-bottom: Black 1pt solid"> </td><td style="text-align: right; border-bottom: Black 1pt solid">1,982,311</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.85pt; padding-left: 8.85pt">Patient Fee Revenue, net of contractual allowances and discounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,307,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,481,865</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.85pt; padding-left: 8.85pt">Provision for Bad Debts</td><td> </td> <td style="text-align: left; border-bottom: Black 1pt solid"> </td><td style="text-align: right; border-bottom: Black 1pt solid">(10,333,082</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left; border-bottom: Black 1pt solid"> </td><td style="text-align: right; border-bottom: Black 1pt solid">(2,584,669</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.85pt; padding-left: 8.85pt">Net Patient Fee Revenue</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,974,110</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,897,196</td><td style="text-align: left"> </td></tr></table>
CY2014	FONR	Export Product Sales ExportProductSales	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Foreign Product Sales, as a Percentage of Product Sales to Unrelated Parties </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 40%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid">For the Years Ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2013</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 30%; text-align: left; padding-left: 5.4pt">Abu Dhabi</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 20%; text-align: right">29.8</td><td style="width: 1%; text-align: left">%</td><td style="width: 24%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 20%; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif">-%</font></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Switzerland</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">England</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Germany</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.1</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">Libya</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.2</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.1</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">42.4</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3.8</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p>
CY2014	FONR	Export Service Revenues ExportServiceRevenues	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Foreign Service and Repair Fees, as a Percentage of Total Service and Repair Fees</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 40%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid">For the Years Ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2013</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 30%; padding-left: 5.4pt">Spain</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 20%; text-align: right">1.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 24%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 20%; text-align: right">0.9</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Puerto Rico</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Switzerland</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.1</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Germany</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">England</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Holland</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">Australia</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1.1</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1.0</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">8.8</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">8.2</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p>
CY2014Q2	us-gaap	Finite Lived Contractual Rights Gross FiniteLivedContractualRightsGross	4100000	usd
CY2013Q2	us-gaap	Finite Lived Contractual Rights Gross FiniteLivedContractualRightsGross	4100000	usd
CY2014Q2	FONR	Customer Relationships Intangible Asset CustomerRelationshipsIntangibleAsset	3800000	usd
CY2013Q2	FONR	Customer Relationships Intangible Asset CustomerRelationshipsIntangibleAsset	3800000	usd
CY2014Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss		usd
CY2013Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	-357500	usd
CY2014Q2	FONR	Amoritization Of Other Intangible Assets AmoritizationOfOtherIntangibleAssets	-1359093	usd
CY2013Q2	FONR	Amoritization Of Other Intangible Assets AmoritizationOfOtherIntangibleAssets	-866719	usd
CY2014Q2	FONR	Total Facilities Owned Or Managed TotalFacilitiesOwnedOrManaged	24	mricenter
CY2013Q2	FONR	Total Facilities Owned Or Managed TotalFacilitiesOwnedOrManaged	24	mricenter
CY2012Q2	FONR	Total Facilities Owned Or Managed TotalFacilitiesOwnedOrManaged	11	mricenter
CY2014Q2	us-gaap	Deferred Income Taxes And Other Assets Current DeferredIncomeTaxesAndOtherAssetsCurrent	5740287	usd
CY2013Q2	us-gaap	Deferred Income Taxes And Other Assets Current DeferredIncomeTaxesAndOtherAssetsCurrent	2935750	usd
CY2014Q2	us-gaap	Goodwill Goodwill	1767098	usd
CY2013Q2	us-gaap	Goodwill Goodwill	1767098	usd
CY2014Q2	us-gaap	Deferred Income Taxes And Other Liabilities Noncurrent DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent	583990	usd
CY2013Q2	us-gaap	Deferred Income Taxes And Other Liabilities Noncurrent DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent	461858	usd
CY2014Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25311608	usd
CY2013Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14114061	usd
CY2014	FONR	Costs Related To Patient Fee Revenue CostsRelatedToPatientFeeRevenue	7670484	usd
CY2013	FONR	Costs Related To Patient Fee Revenue CostsRelatedToPatientFeeRevenue	2704758	usd
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2682405	usd
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2473892	usd
CY2014	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-557473	usd
CY2014	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2013	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-755500	usd
CY2014	FONR	Loss On Management Agreement LossOnManagementAgreement		usd
CY2013	FONR	Loss On Management Agreement LossOnManagementAgreement	357500	usd
CY2014	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	95623	usd
CY2013	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	120976	usd
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13360323	usd
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7539144	usd
CY2014	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-19501	usd
CY2013	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-80499	usd
CY2014	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	3955	usd
CY2013	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	1885	usd
CY2014	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-268261	usd
CY2013	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	253559	usd
CY2014	us-gaap	Increase Decrease In Billing In Excess Of Cost Of Earnings IncreaseDecreaseInBillingInExcessOfCostOfEarnings		usd
CY2013	us-gaap	Increase Decrease In Billing In Excess Of Cost Of Earnings IncreaseDecreaseInBillingInExcessOfCostOfEarnings	142217	usd
CY2014	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	68943	usd
CY2013	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-567914	usd
CY2014	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	295219	usd
CY2013	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-414402	usd
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-270482	usd
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	628033	usd
CY2014	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross		usd
CY2013	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	40000000	usd
CY2014	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment		usd
CY2013	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	700000	usd
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1328315	usd
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1347439	usd
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1368582	usd
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1329294	usd
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1043968	usd
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	4091245	usd
CY2014Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	2890816	usd
CY2013Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	2885769	usd
CY2014Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	8481830	usd
CY2013Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	12887005	usd
CY2014	us-gaap	Income Tax Expense Benefit Extraordinary Items IncomeTaxExpenseBenefitExtraordinaryItems	2682405	usd
CY2013	us-gaap	Income Tax Expense Benefit Extraordinary Items IncomeTaxExpenseBenefitExtraordinaryItems	2473892	usd
CY2014Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	130822	usd
CY2013Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	84136	usd
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2348312	usd
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2277891	usd
CY2014	FONR	Foreign Product Sales ForeignProductSales	.424	pure
CY2013	FONR	Foreign Product Sales ForeignProductSales	.038	pure
CY2014	FONR	Foreign Service And Repair Fees ForeignServiceAndRepairFees	.088	pure
CY2013	FONR	Foreign Service And Repair Fees ForeignServiceAndRepairFees	.082	pure
CY2014	FONR	Fonar2002 Plan Options Expired Fonar2002PlanOptionsExpired	6610	shares
CY2014	FONR	Fonar2002 Plan Options Outstanding Fonar2002PlanOptionsOutstanding	0	shares
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	.34	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	.34	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	.06	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	.06	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-.09	pure
CY2014	us-gaap	Advertising Expense AdvertisingExpense	889000	usd
CY2013	us-gaap	Advertising Expense AdvertisingExpense	835000	usd
CY2014	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	1885	usd
CY2013	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	5838	usd
CY2014Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2014Q2	us-gaap	Cash Cash	8035000	usd
CY2014	FONR	Net Revenues From Related Parties As Percentage Of Consolidated Net Revenues NetRevenuesFromRelatedPartiesAsPercentageOfConsolidatedNetRevenues	0.11	pure
CY2013	FONR	Net Revenues From Related Parties As Percentage Of Consolidated Net Revenues NetRevenuesFromRelatedPartiesAsPercentageOfConsolidatedNetRevenues	0.16	pure
CY2014Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2374339	usd
CY2013Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2321858	usd
CY2014Q2	FONR	Common Stock Available Under Stock Bonus Plan CommonStockAvailableUnderStockBonusPlan	958367	shares
CY2014	FONR	Shares Issued Under Stock Bonus Plan SharesIssuedUnderStockBonusPlan	46708	shares
CY2013	FONR	Shares Issued Under Stock Bonus Plan SharesIssuedUnderStockBonusPlan	67870	shares
CY2002Q3	FONR	Fonar2002 Plan Permitted Issuances Of Stock Options Fonar2002PlanPermittedIssuancesOfStockOptions	100000	shares
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	.006	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.683	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-.762	pure
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-.292	pure
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-.356	pure
CY2014	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P11Y
CY2014	FONR	Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims	0.50	pure
CY2013	FONR	Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims	.41	pure
CY2014	FONR	Percentage Of Consolidated Net Revenue From Management Fees PercentageOfConsolidatedNetRevenueFromManagementFees	0.11	pure
CY2013	FONR	Percentage Of Consolidated Net Revenue From Management Fees PercentageOfConsolidatedNetRevenueFromManagementFees	0.16	pure
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4571000	usd
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4035000	usd
CY2013	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	690000	usd
CY2014	us-gaap	Litigation Settlement Amount LitigationSettlementAmount		usd
CY2013	us-gaap	Litigation Settlement Amount LitigationSettlementAmount	755000	usd
CY2014	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	2665000	usd
CY2014	FONR	Recorded Sales Tax Obligations Interest And Penalties RecordedSalesTaxObligationsInterestAndPenalties	2374000	usd
CY2014	FONR	Recorded Provisions For Penalties Department Of Labor And Internal Revenue Service Regulations Concerning Requirements To File Form5500 To Report Activity Of Its401 K Employee Benefit Plan. RecordedProvisionsForPenaltiesDepartmentOfLaborAndInternalRevenueServiceRegulationsConcerningRequirementsToFileForm5500ToReportActivityOfIts401KEmployeeBenefitPlan.	250000	usd
CY2014	us-gaap	Interest Paid InterestPaid	668475	usd
CY2013	us-gaap	Interest Paid InterestPaid	389907	usd
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	349501	usd
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	277000	usd
CY2014	dei	Entity Registrant Name EntityRegistrantName	Fonar Corporation
CY2014	dei	Entity Central Index Key EntityCentralIndexKey	0000355019
CY2014	dei	Document Type DocumentType	10-K
CY2014	dei	Document Period End Date DocumentPeriodEndDate	2014-06-30
CY2014	dei	Amendment Flag AmendmentFlag	false
CY2014	us-gaap	Other Expenses OtherExpenses	-4835	usd
CY2013	us-gaap	Other Expenses OtherExpenses	-141958	usd
CY2014	us-gaap	Other Income OtherIncome	-608599	usd
CY2013	us-gaap	Other Income OtherIncome	725488	usd
CY2014	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2014	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2014	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2014	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2014	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2014	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q3	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	53200	usd
CY2014Q3	us-gaap	Stock Issued During Period Shares Issued For Cash StockIssuedDuringPeriodSharesIssuedForCash	5000	shares
CY2014Q2	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	5740287	usd
CY2014Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	583990	usd
CY2014Q2	FONR	Net Operating Carryforwards NetOperatingCarryforwards	54900136	usd
CY2013Q2	FONR	Net Operating Carryforwards NetOperatingCarryforwards	58052831	usd
CY2014Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	137252000	usd
CY2014Q2	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	1133000	usd
CY2014	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6392000	usd
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5206000	usd
CY2014Q2	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	57750	usd
CY2014Q2	us-gaap	Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths	2890816	usd
CY2014Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive	305940	usd
CY2014Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	2782561	usd
CY2014Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	2440108	usd
CY2014Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	2372330	usd
CY2014Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive	580891	usd
CY2014Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	11372646	usd
CY2014Q2	FONR	Managment And Other Fees Receivable Related Medical Practices Net Allowances ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances	3426982	usd
CY2013Q2	FONR	Managment And Other Fees Receivable Related Medical Practices Net Allowances ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances	2381664	usd
CY2014Q2	FONR	Accounts Receivable Service And Repair Fees AccountsReceivableServiceAndRepairFees	4450125	usd
CY2013Q2	FONR	Accounts Receivable Service And Repair Fees AccountsReceivableServiceAndRepairFees	4443595	usd
CY2014Q2	FONR	Medical Receivable MedicalReceivable	8807856	usd
CY2013Q2	FONR	Medical Receivable MedicalReceivable	8126476	usd
CY2014Q2	FONR	Management And Other Fees Non Related Parties ManagementAndOtherFees_NonRelatedParties	11970388	usd
CY2013Q2	FONR	Management And Other Fees Non Related Parties ManagementAndOtherFees_NonRelatedParties	11465913	usd
CY2014	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	657350	usd
CY2013	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2014Q2	us-gaap	Shares Issued SharesIssued		shares
CY2013Q2	us-gaap	Shares Issued SharesIssued		shares
CY2012Q2	us-gaap	Shares Issued SharesIssued		shares
CY2013	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation		shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	30600	usd
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2013	FONR	Sale To Non Controlling Interest SaleToNonControllingInterest	19800000	usd
CY2014	FONR	Purchase Of Non Controlling Interest PurchaseOfNonControllingInterest		usd
CY2013	FONR	Purchase Of Non Controlling Interest PurchaseOfNonControllingInterest	-564315	usd
CY2014Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear	1884984	usd
CY2013Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear	1482384	usd
CY2014Q2	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	617592	usd
CY2013Q2	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	303525	usd
CY2014Q2	us-gaap	Billed Contract Receivables BilledContractReceivables	-3013000	usd
CY2013Q2	us-gaap	Billed Contract Receivables BilledContractReceivables	-2370000	usd
CY2014Q2	FONR	Estimated Earnings EstimatedEarnings	1745608	usd
CY2013Q2	FONR	Estimated Earnings EstimatedEarnings	1191141	usd
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	-6610	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	-7412	shares
CY2014Q2	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	9200000	usd
CY2014Q2	us-gaap	Accrued Rent Current AccruedRentCurrent		usd
CY2013Q2	us-gaap	Accrued Rent Current AccruedRentCurrent	147665	usd
CY2014Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	1926813	usd
CY2013Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	1857870	usd
CY2014Q2	FONR	Management Agreements With Company Non Related Medical Practices ManagementAgreementsWithCompanyNonRelatedMedicalPractices	17	mricenter
CY2014Q2	FONR	Management Agreements With Company Related Medical Practices ManagementAgreementsWithCompanyRelatedMedicalPractices	3	mricenter
CY2014Q2	FONR	Management Agreements With Company Total Medical Practices ManagementAgreementsWithCompanyTotalMedicalPractices	20	mricenter
CY2014	FONR	Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders	127504	shares
CY2013	FONR	Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders	127504	shares
CY2010Q3	FONR	Shares Registered Under Form S8 SharesRegisteredUnderFormS8	2000000	shares
CY2005Q1	FONR	Common Stock Authorized Under2005 Stock Option Plan CommonStockAuthorizedUnder2005StockOptionPlan	80000	shares
CY2014	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease	4418903	usd
CY2013Q1	FONR	Controlling Interest Acquired By Company Of Health Diagnostics Management Llc Hdm ControllingInterestAcquiredByCompanyOfHealthDiagnosticsManagementLlcHdm	0.505	pure
CY2013Q1	FONR	Health Diagnostics Management Hdm Class Outside Investors Members Contribution HealthDiagnosticsManagementHdmClassOutsideInvestorsMembersContribution	19800000	usd
CY2013Q1	FONR	Health Diagnostics Management Hdm Class B Company Members Contribution HealthDiagnosticsManagementHdmClassBCompanyMembersContribution	20200000	usd
CY2013Q1	FONR	Company Total Capital Contribution CompanyTotalCapitalContribution	14000000	usd
CY2013Q1	FONR	Interest Rate Of Revolving Credit Loan InterestRateOfRevolvingCreditLoan	0.04	pure
CY2013Q1	FONR	Bank Revolving Credit Loan BankRevolvingCreditLoan	3000000	usd
CY2014Q2	FONR	Hmca Ownership Percentage Of Imperial HmcaOwnershipPercentageOfImperial	.91	pure
CY2014Q2	FONR	Fonar2005 Plan Shares Of Common Stock Available Fonar2005PlanSharesOfCommonStockAvailable	70000	shares
CY2011Q2	FONR	Private Placement Of Equity PrivatePlacementOfEquity	6000000	usd
CY2014Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	1125100	usd
CY2013Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	14244900	usd
CY2014Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3742000	usd
CY2014Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	578000	usd
CY2014	us-gaap	Multiemployer Plan Period Contributions MultiemployerPlanPeriodContributions		usd
CY2013	us-gaap	Multiemployer Plan Period Contributions MultiemployerPlanPeriodContributions		usd
CY2014	FONR	Average Monthly Payment For Stipulation Agreements AverageMonthlyPaymentForStipulationAgreements	19552	usd
CY2014Q2	us-gaap	Liability For Claims And Claims Adjustment Expense Disability Accident And Health LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth	344000	usd
CY2013Q2	us-gaap	Liability For Claims And Claims Adjustment Expense Disability Accident And Health LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth		usd
CY2014	FONR	Stoploss Umbrella Policy With3 Rd Paryinsurer To Limit Maximum Potential Liability For Individual Claims StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims	100000	usd
CY2014	FONR	Export Sales Of Medical Equipment ExportSalesOfMedicalEquipment	.424	pure
CY2013	FONR	Export Sales Of Medical Equipment ExportSalesOfMedicalEquipment	.038	pure
CY2013Q1	us-gaap	Bank Loans BankLoans	11000000	usd
CY2013Q1	us-gaap	Federal Home Loan Bank Advances Interest Rate FederalHomeLoanBankAdvancesInterestRate	0.0475	pure
	FONR	Number Of Consecutive Installments NumberOfConsecutiveInstallments	60	installments
CY2014	FONR	Acquisition Acquisition		mricenter
CY2013	FONR	Acquisition Acquisition	14	mricenter
CY2014	FONR	Internal Development InternalDevelopment	1	mricenter
CY2013	FONR	Internal Development InternalDevelopment		mricenter
CY2014	FONR	Managed Facilities Closed ManagedFacilitiesClosed	1	mricenter
CY2013	FONR	Managed Facilities Closed ManagedFacilitiesClosed	1	mricenter
CY2014	FONR	Net Management Fee Receivables From Related Medical Practices Of Consolidated Accounts Receivable NetManagementFeeReceivablesFromRelatedMedicalPracticesOfConsolidatedAccountsReceivable	0.12	pure
CY2013	FONR	Net Management Fee Receivables From Related Medical Practices Of Consolidated Accounts Receivable NetManagementFeeReceivablesFromRelatedMedicalPracticesOfConsolidatedAccountsReceivable	0.09	pure
CY2010Q2	FONR	Shares Reserved For2010 Stock Bonus Plan SharesReservedFor2010StockBonusPlan	2000000	shares
CY2013Q2	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	.50	pure
CY2010Q2	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	.152	pure
CY2011Q1	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	.348	pure
CY2013Q2	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	700000	usd
CY2011Q1	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	400000	usd
	FONR	Controlling Interest Description ControllingInterestDescription	The Company also has a 50% controlling interest in an entity which the Company consolidates, that provides management services to a diagnostic center in the New York Metropolitan area. The center began operations during January 2012. The noncontrolling interest as of June 30, 2014 and 2013 aggregated $531,474 and $559,221, respectively.

Files In Submission

Name	View Source	Status
0000355019-14-000031-index-headers.html	Edgar Link	pending
0000355019-14-000031-index.html	Edgar Link	pending
0000355019-14-000031.txt	Edgar Link	pending
0000355019-14-000031-xbrl.zip	Edgar Link	pending
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fonar20140630_10k-version10.htm	Edgar Link	pending
fonar_exhibit-21.htm	Edgar Link	pending
fonar_exhibit-23.htm	Edgar Link	pending
fonar_exhibit-31.htm	Edgar Link	pending
fonar_exhibit-32.htm	Edgar Link	pending
fonr-20140630.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
fonr-20140630_cal.xml	Edgar Link	unprocessable
fonr-20140630.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
fonr-20140630_lab.xml	Edgar Link	unprocessable
fonr-20140630_pre.xml	Edgar Link	unprocessable
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
fonr-20140630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FONR
FONAR CORP Stock $fonr

2014 Form 10-K Financial Statement

#000035501914000031 Filed on September 29, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FONR FONAR CORP Stock $fonr

2014 Form 10-K Financial Statement

#000035501914000031 Filed on September 29, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FONR
FONAR CORP Stock $fonr